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Abstract
Objective Closure of atrial septal defects (ASD) prevents
pulmonary hypertension, right heart failure and thromboem-
bolic stroke. The exact timing for ASD closure is
controversial.
Methods In a prospective study to address the question
whether unapparent pulmonary hypertension can be re-
vealed prior to right ventricular (RV) remodelling, patients
were investigated before and 6, 12, and 24 months after
ASD closure using exercise stress echocardiography (ESE)
and ergospirometry (n=24).
Results At rest, RV systolic pressure (RVSP) was normal in
58.8 %, slightly elevated in 26.5 %, and moderately elevated
in 11.8 %. One patient showed severe pulmonary
hypertension. During ESE, all patients with normal RVSP
at rest exhibited an increase (25.7±1.2 mmHg vs. 45.3±
2.3 mmHg, p<0.001). After closure the RVSP was lower,
both at rest and ESE. RV diameters decreased too. Tricuspid
annulus plane systolic excursion (TAPSE) at rest remained
lower after closure (24.0±0.9 vs. 22.0±0.9 mm, p<0.05).
TAPSE in ESE was elevated, and stayed stable after closure
(30.1±1.8 mm vs. 29.3±1.6 mm). Before closure, RV sys-
tolic tissue velocities (sa) at rest were normal and decreased
after closure (14.0±1.0 cm/s vs. 11.5±0.7 (6 month) vs.
10.6±0.5 cm/s (12 month), p<0.05). During ESE, sa veloc-
ity was similar before and after closure (23.0±1.3 cm/s vs.
23.3±1.9 cm/s). Maximal oxygen uptake (VO2/kg) did not
differ between baseline and follow-ups.
Conclusion Latent pulmonary hypertension may become
apparent in ESE. ASD closure leads to a significant reduc-
tion in this stress-induced pulmonary hypertension and to a
decrease in the right heart diameters indicating reverse RV
remodelling. RV functional parameters at rest did not im-
prove. The VO2/kg did not change after ASD closure.
Keywords Pulmonary hypertension . ASD closure .
Exercise stress echocardiography . Ergospirometry
Introduction
Percutaneous closure of atrial septal defects (ASD) and
patent foramen ovale (PFO) has proven to be a promising
therapy for ASD with apparent volume overload of the
pulmonary system and in the prevention of recurrent paradox-
ical embolic events and cryptogenic strokes. During interven-
tion or follow-up complications ranged from 0 to 22 %. In
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some patients, thromboembolic events occur due to clotting of
a device surface [1–4]. Our research group showed a very low
rate of complications in PFO closure [5]. Only a few cases
of partial malposition of PFO closure devices have been
described [6, 7] and only a few reports about cardiac perfo-
ration caused by different PFO and ASD occluder devices
[3, 8–10], which is the most serious complication known,
and mild-to-moderate insufficiencies of the aortic valve [11]
have been reported.
In patients with larger shunts resulting in pulmonary
hypertension, ASD closure resulted in a decline in pulmo-
nary pressures and a reduction in the right ventricular (RV)
and right atrial (RA) volumes and sizes [4, 12].
Asymptomatic patients with smaller shunts without pul-
monary hypertension also increased their functional capac-
ity after ASD closure [13]. Yet patients also developed a
diminution of their aerobic capacity [14]. Thus, the timing
of ASD closure remains controversial.
In the present prospective study, exercise stress echocar-
diography (ESE) and ergospirometry were used to address
the question whether unapparent pulmonary hypertension
and the onset of RV remodelling leading to an impairment
of RV function can be identified in asymptomatic patients in
order to determine the optimal timing for ASD closure.
This study addresses the question whether, in asymptom-
atic patients with ASD, an early pulmonary hypertension
which is unapparent at rest can become evident during stress
testing and may help to identify optimal timing and need for
an interventional or operative ASD closure. Furthermore,
the study also addresses, in a prospective fashion, whether a
subclinical worsening of RV function can be revealed dur-
ing stress testing and this impairment can recover within 6 to
12 months after ASD closure.
Methods
Patients
The study included 59 patients (median age 50 years, range
17–78 years) with a haemodynamically relevant ASD. Pa-
tients with small ASD who did not have relevant alterations
of the right heart diameters and function at rest, clinically all
patients who did not have pulmonary hypertension at rest
and during exercise, without clinical symptoms of heart
failure, and without paradoxical embolism, did not receive
an ASD closure in accordance to AHA guidelines [15], and
were not included into this study.
Twenty-seven patients with normal to moderate pulmo-
nary hypertension at rest received an ESE before, and 6 and
12 months after ASD closure. In addition, 24 patients with a
normal to moderately elevated pulmonary pressure at rest
underwent an ergospirometry before and during follow-up.
Echocardiography
Before study inclusion, each patient (n=59) underwent a
transthoracic two-dimensional echocardiography, according
to the guidelines of echocardiography [16] (TTE, Sonos
5500 ultrasound system, Agilent Technologies, Santa
Clara, California, USA and Sonos 7000 ultrasound sys-
tem, Philips, Amsterdam, the Netherlands) at rest and a
transoesophageal echocardiography (TEE) (Fig. 1a, b) to
characterise the ASD and to measure the maximal ASD
diameter and the surrounding margin, especially the
aortic rim. Echocardiography was also used to calculate:
1) the ratios of pulmonary-to-systemic flow and the
shunt volume, 2) the maximal pulmonary systolic pres-
sure, 3) the diameters of the left and right ventricle and 4)
the function of the left and right heart at rest. Echocardiog-
raphy parameters were chosen for semiquantification of
valve regurgitation or stenosis according to AHA guide-
lines [15].
A total of 27 patients with normal to moderately
elevated pulmonary pressure at rest had a bicycle stress
test in a half-sitting position (30–45°) with a left incline
of 45° (Ergometrics 900, Ergoline, Bitz, Germany). The
stress testing was based on a modified Bruce protocol
[17]: the ergometric load started at 25 W and increased
by 25 W every 3 min. Before and during exercise
(within the third minute), we measured blood pressure
and heart rate. Echocardiography was used simulta-
neously to measure E wave velocity and deceleration
time, tricuspid annulus plane excursion (TAPSE) of the
right ventricle, and the RV systolic pressure (RVSP).
Incompetence of the mitral and tricuspid valves was also
assessed during ESE.
Finally, the tissue Doppler imaging (TDI) values of the
lateral tricuspid valve annulus were collected [18].
Ergospirometry
Patients (n=24) with a normal to moderately elevated pul-
monary pressure at rest and who were in a sufficient phys-
ical condition underwent ergometric bicycle testing (eBike
bicycle ergometer, GE) with a ramp protocol starting at
20 W for warm-up for the first 2 min. The workload was
then increased by 20 W every 2 min until patients reached
their individual performance limitation. The recovery period
lasted at least 3 min. Breath-to-breath measurements of
expired gas values were analysed every 30 s (Oxycon Pro;
Jaeger/Viasys; Höchberg, Germany). Heart rate, blood pres-
sure, and ventilation were recorded continuously during
ergospirometry. The VO2 at the gas exchange anaerobic
threshold was determined with the V-slope method. An ECG
to analyse ST-segment deviations or rhythm disturbance was
recorded continuously during the exercise and recovery period.
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Invasive procedures and percutaneous atrial defect closure
Patients with ASD received a complete cardiac catheterisation
of the left and right heart to determine pulmonary systolic
pressure, pulmonary resistance, and the Qp/Qs ratio (calculat-
ed oxymetrically using the Fick principle). The coronary
angiography was also performed to investigate coronary ves-
sel disease or coronary anomalies.
ASD closure was accomplished in patients with a
pulmonary to systemic flow ratio Qp/Qs>1.5, in the
presence of one or more of the following conditions:
a) RV volume overload, b) impairment of RV function,
c) pulmonary hypertension, d) clinically symptomatic
dyspnoea (NYHA degree II or greater).
Percutaneous closure was performed under local an-
aesthesia (lidocaine 2 %) and sedation with midazolam
(2–5 mg i.v.). The interventional closure procedure was
guided by TEE. Balloon sizing was performed for exact
determination of the ASD size (Fig. 1c).
All patients were anticoagulated at the time of the
procedure with 10,000 IE heparin. They all received
amoxycillin (1.2 g) and atropine (0.5–1.0 mg) intrave-
nously to prevent thromboembolic events, endocarditis
and catheter-induced coronary spasm. Post-intervention
all patients received double platelet inhibition with
clopidogrel 75 mg/day and acetylsalicylic acid
100 mg/day to prevent thrombus formation on the de-
vice. After 6 months the clopidogrel was stopped.
Statistics
Data are means ± standard error of means (SEM).
Student’s t-test for paired samples was used to test for
differences between the individual parameters before
ASD closure and during follow-up. A probability value
of less than 0.05 was considered to be statistically
significant. The statistic analysis was performed with
SPPS 11.5.
Fig. 1 a. Transoesophageal echocardiography (TEE) exhibited a small
ASD in a 42-year-old patient with a washing-off phenomenon
(Echovist® contrast agent) due to a left-to-right shunt before percuta-
neous closure procedure. b. Transoesophageal echocardiography
(TEE) presented a broad ASD in a 61-year-old patient before surgical
patch closure. c. Transoesophageal echocardiography (TEE) during
fluoroscopic balloon-sizing before percutaneous closure procedure. d.
Transoesophageal echocardiography (TEE) demonstrated a percutane-
ous ASD closure with Amplatz® occluder system in a 30-year-old
patient with haemodynamically relevant ASD
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Results
Patient’s characteristics
Fifty-nine patients with ASD were enrolled prospectively:
36 were female (61 %) and the median age at the time of
ASD closure was 50 (17–78) years. The mean body mass
index was 26.2±0.6 kg/m2.
There were 46 patients (78 %) with ASD II, 11 patients
(19 %) with ASD II and PFO, 1 patient (2 %) with ASD I,
and one patient (2 %) with ASD I and PFO.
Sinus rhythmwas present in 74.6% and atrial fibrillation in
25.4 %. Three patients had a history of minor stroke and ten
patients had a history of major stroke. The prevalence of
cardiovascular and metabolic risk factors was as fol-
lows: 27 (45.8 %) arterial hypertension, 20 (33.9 %)
hyperlipoproteinaemia, and 12 (20.3 %) diabetes
mellitus.
Cardiac catheterisation
A haemodynamically relevant coronary heart disease
was found in one patient (occlusion of the right coro-
nary artery (RCA) after previous percutaneous coronary
intervention). Three patients had a coronary anomaly
(single and atypical origin of the left anterior descend-
ing artery, an atypical origin of the circumflex, and an
atypical origin of the RCA). The invasively determined
averaged systolic PAP and pulmonary resistance were in
the upper normal range (PAP 29.0±1.5 mmHg, pulmo-
nary vascular resistance 122.3±10.6 dyn*s*cm−5). The
pulmonary flow to systemic flow ratio was 1.69±0.09, and the
mean value for the left to right shunt was 36.6±1.0 %
(Table 1).
Percutaneous ASD closure was performed and successful
in 49 patients. We used 41 Amplatz Septal Occluders (AGA
Medical Corporation, Plymouth, Massachusetts, USA), and
8 Cardia Star ASD Devices (CARDIA, Eagan, Minnesota,
USA) (Fig. 1d). Eight patients received a surgical ASD
closure due to a small aortic rim, and one patient had a
secondary surgical ASD closure with Amplatz Septal
Occluder after an interventional procedure because of an
ASD relapse. In one patient, a percutaneous ASD closure
with a Cardia Star Device was required after minimal surgical
ASD patch implantation because of a haemodynamically rel-
evant residual shunt volume.
Echocardiography
The mean ASD size measured by TEE was only 13.6±
0.9 mm (SEM). The calculated mean left-to-right shunt
was 37.7±3.4 %, which was in good agreement with the
invasively determined shunt volume. The left ventricular
ejection fraction was in the normal range (64.2±0.8 %),
and the degree of mitral and tricuspid valve insufficiency
were also mild (Table 2).
The diastolic value of the left heart, e.g. maximal early
velocity (E-Vmax) and deceleration time (DT), did not
Table 1 Angiography parameters before ASD closure
mean ± SEM 95 %CI
Qp: Qs 1.69±0.09 (1.50–1.87)
Left right shunt % 36.6±1.0 (34.6–38.7)
Right ventricular systolic pressure mmHg 29.0±1.5 (26.0–32.0)
Right ventricular mean pressure mmHg 16.8±1.0 (14.7–18.8)
Pulmonary vascular resistance dyn*s*cm−5 122.3±10.6 (101.0–143.6)
Table 2 Echocardiography (TTE and TEE) Parameters before ASD Closure
mean ± SEM 95 %CI
ASD size mm 13.6±0.9 (11.8–15.4)
LV ejection fraction % 64.2±0.8 (62.7–65.8)
Left right shunt % 37.7±3.4 (30.6–44.7)
Tricuspid valve insufficiency degree 1.35±0.08 (1.19–1.51)
Mitral valve insufficiency degree 0.89±0.09 (0.72–1.07)
Aortic valve insufficiency degree 0.39±0.09 (0.21–0.56)
Pulmonary valve insufficiency degree 0.31±0.07 (0.17–0.45)
E velocity max. cm/s 91.1±4.3 (82.4–99.8)
Deceleration time ms 197.1±7.5 (182.1–212.2)
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change significantly during follow-up, neither at rest nor
during exercise (Table 3).
The RVSP before closure was in the normal range at rest
(<35 mmHg) in 27 patients (55.1 %). There was mild
Table 3 Diastolic inflow parameters of the left heart at Rest and at Peak Exercise
Before ASD closure Month 6 Month 12
E Vmax [cm/s] Rest 88.7±7.0 79.3±9.0 71.1±11.3
n 21 8 7
P* (95 %CI 74.0–103.4) 0.61 0.42
Exercise 126.6±6.7 141.3±11.6 124.5±11.8
n 20 6 6
P* (95 %CI 112.6–140.6) 0.13 0.34
DT [ms] Rest 206.3±10.7 213.9±19.7 236.6±28.1
n 22 8 8
P* (95 %CI 184.0–228.7) 0.96 0.358
Exercise 156.1±7.1 144.4±6.1 165.7±7.9
n 20 7 6
P* (95 %CI 141.3–170.8) 0.24 0.47
*paired comparisons with baseline data before ASD closure
Fig. 2 a. Normal RVSP at rest increased significantly during exercise. b. Mild elevated RVSP at rest increased significantly during exercise.
c. Moderate to severe RVSP at rest increased during exercise
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pulmonary hypertension at rest (35–49 mmHg) in 16 pa-
tients (32.7 %), moderate pulmonary hypertension (50–
69 mmHg) in 5 patients (10.2 %), and severe pulmonary
hypertension at rest (≥70 mmHg) in 1 patient (2.0 %).
During ESE, most of the patients with normal RVSP at rest
exhibited a significant increase in the RVSP (25.7±1.2 mmHg
up to 45.3±2.3mmHg; p<0.001); only three patients remained
in the normal range. The incline of the RVSP reached pulmo-
nary hypertension of at least a moderate degree in eight pa-
tients. In detail, patients with mild pulmonary hypertension
developed a moderately elevated PAP. In three patients the
RVSP increased even beyond 60 mmHg (from 40.2±
1.8 mmHg up to 65.7±3.6 mmHg; p<0.001). Five patients
with moderate to severe pulmonary hypertension before ASD
closure had an increase of RVSP during exercise from 56.3±
2.2 mmHg up to 76.5±7.5 mmHg (p=0.062) (Fig. 2a–c).
During follow-up the RVSP decreased significantly in all
patients at rest and also during exercise. This reduction
reached significance at month 6 at rest and at month 12 in
ESE (Figs. 3a–c and 4a–c). RVSP results at rest and during
exercise are summarised in Table 4.
The diameters of the right atrium and right ventricle
declined soon after ASD closure.
TAPSE and TDI Doppler sa [18, 19]: The mean ±
SEM (95 % CI) TAPSE at rest before ASD closure was
24.0±0.9 (95 % CI: 22.1–25.9), thus within the normal
range. During exercise, TAPSE increased 30.1±1.8 mm
(95 % CI: 26.4–33.8). After ASD closure, TAPSE at
rest decreased significantly, but TAPSE measured during
exercise did not change significantly. In contrast, these
values were lower than equally determined peak values
in healthy volunteers (TAPSE up to 33.7±1.1 mm)
(unpublished data).
Another parameter of RV function was systolic TDI veloc-
ities at the lateral tricuspid annulus (sa) [18]. Before closure,
TDI sa values at rest were in the normal range (14.0±1.0 cm/s
(95 % CI: 12.0–16.1) and decreased significantly after ASD
closure.
During ESE the TDI sa values increased to 23.0±
1.3 cm/s (95 % CI: 20.2–25.8) before ASD closure. These
peak exercise values remained stable during follow-ups. In
comparison, TDI sa values in healthy volunteers increased to
Fig. 3 a. RVSP at rest decreased significantly after ASD closure at month 6. b. RVSP at rest before and 12 months after ASD closure. c. RVSP at
rest before and 24 months after ASD closure
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25.2±0.7 cm/s (unpublished data). Right heart values and
functional parameters are summarised in Table 5.
Ergospirometry
Comparison of the maximal oxygen uptake (VO2 max,
VO2/kg) before and after ASD closure did not differ signif-
icantly between baseline values and follow-up. Only the
measured oxygen uptake at the anaerobic threshold (VO2-AT)
at month 6 was significantly decreased, but rose again during
further follow-up. The nominal oxygen capacity before
closure was nearly 95 %, but it did not change significantly
after ASD closure.
The peak ventilation (VE) was elevated during follow-
up, significantly so by the end of the follow-up period.
Breathing equivalents of CO2 at the anaerobic threshold
increased slightly but significantly at months 12 and 24.
Breathing equivalents of O2 at the anaerobic threshold were
increased significantly at months 12 and 24 but the magni-
tude of increase was not clinically meaningful. Only the
mean breathing equivalents for CO2 at month 24 were out
of the normal range (30.8±0.9).
Fig. 4 a. RVSP during exercise before and 6 months after ASD closure. b. RVSP at during exercise before and 12 months after ASD closure.
c. RVSP at during exercise before and 24 months after ASD closure
Table 4 Right ventricular systolic pressure at rest and peak exercise before ASD closure






RVSP at rest 26.6±5.1 40.4±4.5 57.0±4.1 74
n 27 16 5 1
RVSP during exercise 28.0±7.2 42.4±3.9 56.2±4.8 78.0±8.1
n 3 9 14 8
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The oxygen pulse, a parameter that correlates with stroke
volume, did not change significantly.
Ergospirometry results are summarised in Table 6.
Discussion
The salient findings of the present prospective study are
that:
1) Clinically asymptomatic patients with ASD yet with
normal baseline pulmonary pressures at rest may reveal
significantly elevated pulmonary pressures during stress
test and that
2) The elevated pulmonary pressures may be rapidly
normalised after interventional or operative ASD
closure.
The increase in pulmonary pressure during exercise was
not unexpected [20] yet the association with clinically
completely asymptomatic patients has not been shown pre-
viously to this extent. Moreover, the rapidity of the recovery
of the stress-induced increase of pulmonary pressure after
successful ASD closure in asymptomatic patients has not
been shown before.
The right heart diameters declined soon after ASD clo-
sure. These data confirm previously published data [4, 12,
13, 20, 21]. In previous studies, the magnitude and time
course of cardiac remodelling did not differ significantly
between age groups, but the right ventricle remained larger
in older patients [20–24].
Hence our interest focused on RV functional parameters:
The M-mode measurement of the TAPSE was used in an
attempt to evaluate the quality of right heart contraction.
TAPSE seems to be a powerful parameter for reflecting RV
function in pulmonary arterial hypertension [25]. In the pres-
ent study, TAPSE was reduced during follow-up in contrast to
expectation. Previous studies have described TAPSE at rest
but have also shown attenuation in patients with right and/or
left heart failure [19, 26]. In the present study TAPSE was
within the normal range at baseline and as expected signifi-
cantly increased during the stress test. In contrast to expecta-
tion, TAPSE at rest significantly decreased after ASD closure.
Considering the observation that ASD closure even improved
pulmonary pressures under stress, it seems unlikely that the
reduction of TAPSE after ASD closure reflects an impairment
of RV function. Potentially, the geometric changes after de-
vice implantation or surgical ASD closure alter basal excur-
sion of the right ventricle. Consequently the parameter TAPSE
may be an inadequate parameter to estimate RV function
in these patients. This notion is supported by the obser-
vation that RV volumes have normalised after ASD clo-
sure suggesting haemodynamic improvement of these patients.
A normalisation of RV volumes has been shown before after
ASD closure [24].
Table 5 Right heart diameters and functional parameters
Before ASD closure Month 3 Month 6 Month 12 Month 24 Month 36
Right atrium [mm] 45.2±0.9 40.5±0.6 40.8±1.0 39.7±1.1 41.5±1.3 41.2±3.4
n 50 39 33 29 18 6
P* < 0.001 < 0.001 <0.001 <0.05 0.58
Right ventricle [mm] 36.2±0.8 33.6±1.1 32.2±0.9 32.1±1.1 32.8±1.2 31±1.6
n 50 39 33 29 18 6
P* <0.05 <0.001 <0.01 <0.05 0.33
TAPSE at rest [cm] 24.0±0.9 23.2±0.9 22.0±1.0 22.0±0.9 23.2±1.7
n 37 23 19 19 5
P* 0.443 0.05 0.05 0.315
TAPSE at peak exercise [cm] 30.1±1.8 26.1±1.8 29.3±1.6 23.2±1.7
n 25 9 12 5
P* 0.075 0.8 0.315
Sa velocity at rest [cm/s] 14.02±0.98
(95 %CI 11.98–16.05)
11.49±0.68 10.63±0.45
n 21 9 6
P* <0.05 0.01
Sa velocity at peak exercise [cm/s] 23.00±1.33
(95 %CI 20.22-25.78)
20.63±1.82 23.3±1.91
n 20 9 5
P* 0.179 0.664
* paired comparisons with baseline data before ASD closure
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Measurement of the TDI strain velocities of the right
ventricle wall was used as another attempt to character-
ise the RV function. An animal study in dogs provided
evidence of a strong correlation between systolic TDI
velocities (sa) and RV contractility [27]. A limited study
in patients presented a good correlation between tissue
displacement and strain and RV stroke volume index
measured by the method of Fick or by thermodilution
[28]. In recent studies in patients after ASD closure, it
was reported that ASD closure resulted in a decrease in
TDI regional peak strain of the right ventricle [29–31].
Congruently, we found that peak strain velocities in the
lateral tricuspid annulus area were significantly reduced
after ASD closure and were in a lower but normal range
compared with healthy volunteers. Our results agree
partially with a study that showed a transient deteriora-
tion of the RV function after ASD closure, as
ascertained by RV Tei index [24]. In contrast, a study
exhibited an improvement of RV function after
transcatheter closure of ASD [32]. However, in this
study the time interval between ASD closure and echo-
cardiographic examination was in the wide range of 8 to
270 days and could not be used as a valid comparison
with our data.
In addition, we found that this peak systolic strain
increased significantly during exercise, without impor-
tant differences in the exercise tests before vs. after
ASD closure. This observation could be an indication
of the preserved RV functional capacity in these pa-
tients. Future studies will point out the significance of
the peak systolic strain value during exercise in the
decision regarding ASD closure in patients with clini-
cally relevant impaired RV function. However, in our
study there were no patients with symptoms of severe
right heart failure.
A significant decrease in maximal oxygen consump-
tion with ageing has been found in various congenital
heart diseases, especially in tetralogy of Fallot, Ebstein’s
anomaly and of course in atrial septal defects [14]. The
preoperatively reduced cardiopulmonary exercise capac-
ity in adults with ASD improved slightly 4 months after
ASD closure and normalised 10 years after surgical
shunt closure [33]. In addition, patients with percutane-
ous ASD closure presented a significant improvement in
Table 6 Ergospirometry parameters
Before ASD closure Month 6 Month 12 Month 24
Oxygen (VO2) Max [ml/min] 1656.9±134.5 1677±205.3 1723.1±199.2 1800.8±142.4
n 24 12 13 6
P* 0.57 0.50 0.18
Anaerobic threshold [ml/min] 1032.8±66.1 954.6±88.4 1085±120.5 1101.8±147.6
n 22 11 11 6
P* <0.05 0.27 0.43
Nominal [%] 94.7±5.5 93.0±6.9 96.1±9.4 94.3±5.8
n 21 11 12 6
P* 0.63 0.38 0.25
Per body weight [ml/min/kg] 23.6±2.1 24.3±2.9 24.8±3.1 23.2±2.3
n 24 12 13 6
P* 1 0.71 0.34
Peak ventilation Mean [l/min] 32.6±2.1 53.7±5.6 49.67±5.8 62.8±4.3
n 23 11 10 6
P* 0.12 0.52 < 0.01
Breathing equivalents Eq CO2 anaerobic threshold 26.6±1.6 24.3±2.6 26.2±2.4 30.8±0.9
n 22 11 9 6
P* 0.27 <0.05 < 0.01
Eq O2 anaerobic threshold 21.6±1.1 21.1±2.3 24.0±2.0 26.6±0.7
n 22 11 11 6
P* 0.65 < 0.01 <0.01
Peak oxygen pulse Peak exercise [ml] 11.6±0.7 12.0±1.3 12.7±1.0 12.1±1.2
n 23 11 12 6
P* 0.77 0.48 0.35
*paired comparisons with baseline data before ASD closure
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their exercise capacity at month 6 [13] and month 12,
respectively [32]. This improvement was observed even
in patients classified as asymptomatic, in those with
lesser shunts (Qp:Qs≤2.0), and in older patients [13].
Patients, who did not achieve a normal exercise capacity
after 3 years from closure had a severely depressed pre-
closure peak oxygen uptake [22].
In our study, ergospirometry before ASD closure and
during follow-up showed no relevant changes in the maxi-
mum individual oxygen capacity or the oxygen pulse, be-
fore vs. after ASD closure. Nonetheless, the oxygen uptake
at the anaerobic threshold at month 6 was significantly
reduced but was increased at later follow-ups. Our patients
also showed an increase of peak ventilation after ASD
closure. The sensitive but unspecific breathing equivalents
for CO2 and O2 rose slightly after the closing procedure but
remained in the normal range (except VE/CO2 at month 24).
These findings might contrast with previously reported data
from various study groups [13, 20, 22, 29, 34]. Potentially,
the patients in the present study were healthier than the
patients in those earlier studies. In the present study nearly
normal (95 %) nominal oxygen capacity before closure
could be documented. However, in previous studies the
pre-closure peak oxygen consumption was 50 to 63 % [20,
33, 35]. In comparison with previous studies, our patients
had lower right ventricle systolic pressure before ASD clo-
sure and a lower pulmonary to systemic flow ratio. Abnor-
mal RVSP at rest was established as the exclusive parameter
affecting cardiopulmonary exercise capacity in patients with
ASD. Patients with higher RVSP reached significantly ear-
lier the anaerobic threshold [20, 25].
Two major limitations of the study should be discussed.
First, some patients missed their follow-ups or were unwill-
ing to have exercise tests before and/or during follow-up,
especially at month 24 or 36 after ASD closure. However, a
paired comparison permitted a statistically valid analysis.
Second, the number of patients in our study was not suffi-
cient to perform subgroup analysis on which patients
benefited most from ASD closure.
Conclusion
Pulmonary hypertension is the most important complication
in patients with haemodynamically relevant ASD, and se-
vere pulmonary hypertension predicts shortened life expec-
tancy. Patients with ASD often have latent pulmonary
hypertension that becomes apparent during exercise. ASD
closure, especially by ASD septal occluder systems, led to a
significant reduction in pulmonary hypertension at rest and
also during exercise and also to a distinct decrease in the
right heart volumes and diameters. In contrast, functional
parameters of the right ventricle at rest did not improve after
ASD closure, and the maximum individual oxygen capacity
did not change after ASD closure.
However our findings, especially the reduced pulmonary
pressure during exercise stress, should help physicians in
their decision regarding early ASD closure in this kind of
patients.
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